CAR-T cells therapy is showing remarkable responses in patients with hematological malignancies. However, cell therapies appear currently far less effective in patients with solid tumors. How (and if) CAR-T cells could work in solid tumors is one of the main questions the global scientific community is facing nowadays. Let’s listen to Chrystal M. Paulos (Department of Microbiology and Immunology Hollings Cancer Center, Medical University of South Carolina, Charleston), that we met in Naples at Immunotherapy Bridge 2019.
FONTE: www.oncoinfo.it
